Unresectable Malignant Solid Neoplasm Terminated Phase 1 Trials for Cemiplimab (DB14707)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0110416 (Unresectable Malignant Solid Neoplasm) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04729725 | SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL | Treatment |